These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, Spirito P. N Engl J Med; 2000 Feb 10; 342(6):365-73. PubMed ID: 10666426 [Abstract] [Full Text] [Related]
5. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy. Cotiga D, Ehlert F, Sherrid M. Anadolu Kardiyol Derg; 2006 Dec 10; 6 Suppl 2():55-60. PubMed ID: 17162272 [Abstract] [Full Text] [Related]
10. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. Maron BJ, Spirito P. J Cardiovasc Electrophysiol; 2008 Oct 10; 19(10):1118-26. PubMed ID: 18384577 [Abstract] [Full Text] [Related]
12. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties. Przybylski A, Małecka L, Pytkowski M, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Ruzyłło W, Szwed H. Kardiol Pol; 2005 Oct 10; 63(4):391-7; discussion 398. PubMed ID: 16273479 [Abstract] [Full Text] [Related]
13. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation]. Jastrzebski M, Czarnecka D, Bacior B, Petkow-Dimitrow P, Wilczek R, Kawecka-Jaszcz K. Kardiol Pol; 2005 Aug 10; 63(2):191-5; discussion 196. PubMed ID: 16136416 [Abstract] [Full Text] [Related]
15. [Interventional treatment in hypertrophic cardiomyopathy]. Gietzen FH, Schümmelfeder J, Neuser H, Brunn J, Schumacher B, Kerber S. Herz; 2005 Mar 10; 30(2):102-10. PubMed ID: 15875098 [Abstract] [Full Text] [Related]
16. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy. You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M. Am Heart J; 2007 Nov 10; 154(5):899-907. PubMed ID: 17967596 [Abstract] [Full Text] [Related]
17. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM]. Maron BJ, Spirito P. Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr 10; 37(4):297-302. PubMed ID: 19791462 [Abstract] [Full Text] [Related]
18. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA. Heart; 2009 May 10; 95(9):709-14. PubMed ID: 19282314 [Abstract] [Full Text] [Related]
19. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death. Ostman-Smith I. Fundam Clin Pharmacol; 2010 Oct 10; 24(5):637-52. PubMed ID: 20727015 [Abstract] [Full Text] [Related]
20. [Hypertrophic cardiomyopathy with two episodes of recuperated sudden death. Report of the first implantable defibrillator cardioverter inserted in Chile]. Zalaquett R, Fajuri A, Irarrázaval MJ, Neghme R, Vergara I, Sacco C, Dubernet J, Corbalán R. Rev Med Chil; 1994 Oct 10; 122(10):1171-7. PubMed ID: 7659885 [Abstract] [Full Text] [Related] Page: [Next] [New Search]